RecruitingNot applicableNCT06719440
Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Studying Embryonal tumor of neuroepithelial tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Principal Investigator
- Dario Di Perri, MDCliniques universitaires Saint-Luc- Université Catholique de Louvain
- Intervention
- Radiotherapy (CTV=10mm)(radiation)
- Enrollment
- 347 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2031
Study locations (23)
- Olv Azorg, Aalst, Belgium
- EpiCURA, Baudour, Belgium
- AZ Sint Jan, Bruges, Belgium
- Institut Jules Bordet, Brussels, Belgium
- UZ Brussel, Brussels, Belgium
- Cliniques universitaires Saint-Luc, Brussels, Belgium
- Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium
- AZ Sint-Lucas, Ghent, Belgium
- UZ Gent, Ghent, Belgium
- Grand Hôpital de Charleroi, Gilly, Belgium
- JESSA Ziekenhuis, Hasselt, Belgium
- AZ Groeninge, Kortrijk, Belgium
- Chu Helora, La Louvière, Belgium
- UZ Leuven, Leuven, Belgium
- CHU Liège, Liège, Belgium
- +8 more locations on ClinicalTrials.gov
Collaborators
Belgium Health Care Knowledge Centre
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06719440 on ClinicalTrials.govOther trials for Embryonal tumor of neuroepithelial tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07488754Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)Medical University of Warsaw
- RECRUITINGPHASE1NCT07025018Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsHutchmed
- RECRUITINGPHASE2NCT06558214OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialUniversity of Florida
- RECRUITINGPHASE3NCT06496971A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsNaviFUS Corporation
- RECRUITINGPHASE2NCT07364786Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaPeter Siesjö
- RECRUITINGEARLY PHASE1NCT06828341A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 ExpressionJIANG LONGWEI
- RECRUITINGPHASE2NCT05708352A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care TreatmentCedars-Sinai Medical Center
- RECRUITINGPHASE1NCT05030298Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma TrialMayo Clinic
See all trials for Embryonal tumor of neuroepithelial tissue →